Covaxin for Children Proven to be Safe in Phase II/III Study
The clinical trials conducted in the pediatric population between June 2021 to September 2021 have shown robust safety, reactogenicity, and immunogenicity. The data was submitted to the…
Browsing Tag
Covaxin For Children
Covaxin for Children: Study says robust safety, immunogenicity in 2-18 year old…
Bharat Biotech had conducted phase II/III, open-label, and multicenter studies to evaluate the safety, reactogenicity, and immunogenicity of Covaxin in healthy children and adolescents in…
DGCI nod to Covaxin for use in children above 12 years with certain conditions
The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech’s EUA application had recommended granting emergency use approval to Covaxin for use in…
Wait for Covaxin’s Covid-19 jab for children gets longer
The data for Bharat Biotech's Covaxin for Children, the vaccine against coronavirus disease (Covid-19) for children, is under evaluation and the process would more time for final approval…
Vaccination for children to begin soon, private hospitals gear up to facilitate…
By Aarushi BatraAs the Drugs Controller General of India (DCGI) granted Emergency Use Authorization (EUA) to Zydus Cadila’s ZyCoV-D vaccine and Subject Expert Committee (SEC) recommended…
Experts hail Covaxin approval for 2-18 year olds, favour use on children with…
The just approved vaccine from Bharat Biotech is for 2 to 18 year olds.Children in India now have a choice in terms of COVID-19 vaccines with Bharat Biotech becoming the second company after…
Bharat Biotech submits clinical trial data for paediatric vaccine to DCGI
The wait for a paediatric Covid-19 vaccine for children over two years may soon be over if India’s drug regulator…
Covaxin for Children to Get DGCI Approval Before Trial
A total of 90 children were subjected to Covaxin trials in Karnataka. ‘Zydus Cadila, a leading pharmaceutical company in India was recently authorized by DCGI for its needle-free ZyCoV-D…